Risk stratification using coronary artery calcium and potential benefit of semaglutide therapy: A cost‐effectiveness modelling study
CAC scores have potential use as a tool to estimate potential clinical benefit and cost for lifetime semaglutide therapy among obese individuals.
Authors
- Robert Okyere
- Ian J. Neeland (ORCID: https://orcid.org/0000-0003-2831-3618)
- Santosh Kumar Sirasapalli (ORCID: https://orcid.org/0009-0003-9373-8310)
- Salil Deo
- Niketh Surya
- Kanimozhi Sivanantham
- Tong Zhang
- Sai Rahul Ponnana
- Sanjay Rajagopalan
- Shamsa Elhussain
- Jean‐Eudes Dazard
- Zhuo Chen
Institutions
- Cleveland Clinic (US)
- University Hospitals of Cleveland (US)
- University Hospitals Cleveland Medical Center (US)
- Louis Stokes Cleveland VA Medical Center (US)
- Case Western Reserve University (US)
- University of Glasgow (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-02-02
- DOI
- https://doi.org/10.1111/dom.70515
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00